Kidney-transplant rejection and anti-MICA antibodies [7]

New England Journal of Medicine

Volumn 358, Issue 2, 2008, Pages 196-

  Dragun, Duska ^a   Scornik, Juan ^b   Meier Kriesche, Herwig Ulf ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA A ANTIGEN; ANTIBODY; HLA ANTIGEN CLASS 1; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; UNCLASSIFIED DRUG;

GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; LETTER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; ACUTE DISEASE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; NOTE; PHYSIOLOGY;

ACUTE DISEASE; ANTIBODIES; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KIDNEY TRANSPLANTATION;

EID: 38049177873     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Meier-Kriesche H-U, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4:378-83.
2. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant 2007;7:1808-14.